August 2013

The following articles make reference to Epidarex Capital under its previous name.

Apellis Pharmaceuticals Inc. Raises Series C Financing

Louisville, Kentucky – August 21st, 2013 – Rock Spring Ventures has increased its investment in Apellis Pharmaceuticals Inc., an early-stage biotechnology company focused on developing a novel pipeline of anti-inflammatory products through a combination of in-licensing of preclinical compounds and in-house research and development. Apellis…